InsidersTradesSigma
Discover the full record of transactions filed by Hahn Brian M., Chief Financial Officer. Insider active across 1 companies, notably Glycomimetics INC. In total, 1 filings have been recorded. Total volume traded: €3k. The latest transaction was disclosed on 9 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Brian M. Hahn is the Chief Financial Officer at GlycoMimetics Inc. He oversees the financial operations of the company, including financial planning and reporting. GlycoMimetics Inc. is a biopharmaceutical company focusing on developing treatments for serious diseases.